A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycanJihee Kim, Yung‐Yao Lin, Christin Luft et al.|EMBO Reports|2019Cited by 23
Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological correctionsAmaia Paredes‐Redondo, Yung‐Yao Lin, Peter Harley et al.|Science Advances|2021Cited by 19
CRISPR-mediated correction of skeletal muscle Ca2+ handling in a novel DMD patient-derived pluripotent stem cell modelCristina Morera, Yung‐Yao Lin, Jihee Kim et al.|Neuromuscular Disorders|2022Cited by 5